World Duchenne Organization

World Duchenne Organization
wdo_logo_large

Health conditions and target population approached by WDO:

Caregivers of patients with Duchenne Muscular Dystrophy. Experienced adherence challenges are that caregivers are given advice and materials to understand what care is needed for their children and what to avoid in case of an emergency, but the materials are often so overwhelming that caregivers do not understand the content. WDO has their headquarters in the Netherlands and has an umbrella organisational structure with member organisations in different countries. Caregivers will be recruited through WDO and the member organisations.

WDO is a non-profit worldwide organisation dedicated to finding a cure and viable treatments for DMD. WDO is also a Members of EURORDIS, RDI and EPF. The organisation’s overarching goals are to promote research activities and provide information to patients and their families as well as clinicians, on current research, drug development, standards of care (SOC) and patient advocacy. It has 45 member patient organisations across Europe and the globe.

Health conditions and target population approached by WDO:

Caregivers of patients with Duchenne Muscular Dystrophy. Experienced adherence challenges are that caregivers are given advice and materials to understand what care is needed for their children and what to avoid in case of an emergency, but the materials are often so overwhelming that caregivers do not understand the content. WDO has their headquarters in the Netherlands and has an umbrella organisational structure with member organisations in different countries. Caregivers will be recruited through WDO and the member organisations.

WDO is a non-profit worldwide organisation dedicated to finding a cure and viable treatments for DMD. WDO is also a Members of EURORDIS, RDI and EPF. The organisation’s overarching goals are to promote research activities and provide information to patients and their families as well as clinicians, on current research, drug development, standards of care (SOC) and patient advocacy. It has 45 member patient organisations across Europe and the globe.